15 Miss. Code. R. 22-9.4 - Education Regarding the Risks and Benefits of Medical Cannabis
9.4.1 Education on the risks and benefits of
the use of medical cannabis between a registered practitioner and/or medical
cannabis establishment and a qualified patient, caregiver, parent, or legal
guardian is permissible. This education is not considered advertising or
marketing.
9.4.2 Education on the
risks and benefits of the use of medical cannabis between a registered
practitioner and/or medical cannabis establishment and a qualified patient,
caregiver, parent, or legal guardian can also include written or video
educational materials that are inclusive of the medical cannabis
establishment's brand.
9.4.3
Education provided to a qualified patient, caregiver, parent, or legal guardian
by a registered practitioner and/or medical cannabis establishment that
includes instruction/direction on the safe use of medical cannabis and/or
medical cannabis products is permissible.
9.4.4 Except as otherwise provided in this
Part the use of pictures and/or images of cannabis and/or cannabis products
shall be limited to patient education materials.
9.4.5 A registered practitioner or medical
cannabis establishment may provide educational materials about cannabis to
qualifying patients and/or their designated caregivers, parents and/or legal
guardians. Educational materials shall adhere to the following:
A. Information about the potential risks and
side effects of medical cannabis use, including the risk of poisoning and the
number for the closest poison control center shall be included;
B. Information to assist in the selection of
cannabis, describing the potential differing effects of various strains of
cannabis, as well as various forms and routes of administration, purported
effectiveness of various methods, and the differences in the anticipated time
frames for the forms to take affect may be included;
C. Materials offered to registered qualifying
patients and their personal caregivers to enable them to track the strains used
and their associated effects may be included;
D. Information on tolerance, dependence, and
withdrawal may be included;
E.
Information regarding substance abuse signs and symptoms, as well as referral
information for substance abuse treatment programs; and,
F. Other warnings, instructions, and/or
directions on the safe use of medical cannabis and/or medical cannabis products
which the registered practitioner and/or medical cannabis establishment deems
appropriate.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.